On May 7, 1994, Qinghai Sanpu Pharmaceutical Co., Ltd. was established.

With the approval of the China Securities Regulatory Commission, on January 12, 1995, 15 million RMB Class A shares (including employee shares) were publicly issued to the public on the Shanghai Stock Exchange through bidding and online issuance. In February 1995, On the 6th, the company's 15 million public shares were approved to be listed on the Shanghai Stock Exchange, of which employee shares were also approved for listing and trading. It is the first listed company in Qinghai Province.

On January 11, 1996, Qinghai Pharmaceutical Co., Ltd. was established.

In 1996, the company initiated and organized the "First China Tibetan Medicine and Natural Medicine Development Strategy Seminar" and included some of the seminar topics in the company's long-term development strategy. It also initiated the establishment of the "Qinghai Province Chinese and Tibetan Medicine Promotion Association" composed of more than 30 national and provincial experts.

In June 1997, "Jiangheyuan" brand "Sanpu Hepatitis B Jian", "Sanpu Rhodiola Capsules" and "Yongji" brand "Cordyceps Essence" were listed in the "97 Spring Qinghai Province Consumer Goods" "Recommendation Activity" won the gold medal; "Sanpu Hepatitis B Jian" and "Lifei Tablets" won the first batch of famous brand product certificates in Qinghai Province.

On October 18, 1997, Qinghai Qingtai Trust Investment Co., Ltd. was established.

In November 1997, Qinghai Pharmaceutical Co., Ltd. obtained the national GSP certification.

In 1998, the company's main product "Hepatitis B Jian" entered the "National Essential Drugs Catalog".

In 1999, "Sanpu Hepatitis B Jian Tablets" was rated as a national protected variety of traditional Chinese medicine.

In 2000, the company's "Sanpu" trademark was rated as a "Famous Trademark of Qinghai Province" by the Qinghai Provincial Administration for Industry and Commerce.

In 2001, the company was recognized as a "High-tech Enterprise" by the Qinghai Provincial Department of Science and Technology, and Hepatitis B Jian Tablets was designated as a "Qinghai Provincial High-tech Product" by the Qinghai Provincial Department of Science and Technology.

On November 13, 2002, the company's three dosage forms of tablets, capsules and granules passed the GMP national quality certification.

In 2003, the company's main product "Lifei Tablets" was recognized as a "High-tech Product of Qinghai Province" by the Qinghai Provincial Department of Science and Technology.

In 2003, the company's "Sanpu" trademark was rated as a "Famous Trademark of Qinghai Province" by the Qinghai Provincial Administration for Industry and Commerce.

In 2003, the company won the honorary title of "Qinghai Province Integrity Enterprise" and Xining City's "Contract-abiding and Trustworthy Enterprise" title.

On November 28, 2003, the company name was changed from "Qinghai Sanpu Pharmaceutical Co., Ltd." to "Sanpu Pharmaceutical Co., Ltd."

In September 2004, Qinghai Pharmaceutical Co., Ltd. and Qinghai Sanpu Pharmaceutical Chain Co., Ltd. passed the GSP tracking inspection of the State Food and Drug Administration.

In October 2004, the company's pills, oral liquids and decoctions passed the GMP national quality certification.

In January 2005, the company was awarded the title of "Advanced Tax Payment Enterprise in Qinghai Province" by the People's Government of Qinghai Province. Qinghai Pharmaceutical Co., Ltd. was awarded the title of “Class A Model Taxpayer” by the Qinghai Provincial State Taxation Bureau and the Qinghai Provincial Local Taxation Bureau.

In April 2005, the company's health food (capsules) passed the GMP national quality certification.

In June 2005, the company won the honorary title of "Abide by Contracts and Value Credit" awarded by Xining Municipal Administration for Industry and Commerce.

Effective from June 8, 2005, the delisting risk warning and other special treatments implemented for the company's stock trading were revoked, and the stock abbreviation was restored from "*st Sanpu" to "Sanpu Pharmaceutical".

On July 19, 2005, the "Three General Purifications" Forum on the Modernization of Chinese and Tibetan Medicine on the Qinghai-Tibet Plateau was held in Xining.

In September 2005, the company's tinctures passed the GMP national quality certification.

On September 15, 2005, the company and Qinghai Pharmaceutical Co., Ltd. were awarded the title of "Integrity Enterprise" by the Qinghai Banking Association.

In October 2005, Qinghai Pharmaceutical Co., Ltd. won the honorable title of Qinghai Top 100 Commercial Enterprises in 2005.

On December 26, 2005, the company’s share-trading reform plan was reviewed and approved by the relevant shareholders’ meeting. It is the first listed company in Qinghai Province to pass the share-trading reform. ;

In April 2006, Qinghai Pharmaceutical Co., Ltd. passed the certification inspection of the Qinghai Provincial Food and Drug Administration.

In April 2006, the New Special Drug Station of Qinghai Provincial Pharmaceutical Co., Ltd. won the honorary title of the first batch of "50 non-public enterprises that pay taxes in good faith according to law" in Qinghai Province.

In August 2006, the company's "Qifeng Granules Modern Chinese Medicine High-tech Industrialization Demonstration Project" fully passed the acceptance inspection.

In December 2006, Qinghai Pharmaceutical Co., Ltd. successfully passed the GSP drug quality certification inspection.

In December 2006, the company's Rhodiola rosea capsules and Haoxue capsules were approved for export registration.

In January 2007, the company won the honorable title of "Advanced Tax Payment Enterprise in Qinghai Province".

In March 2007, the company's "Sanpu" trademark was recognized as a famous trademark in Qinghai Province.

In November 2007, the company's capsules, tablets, granules, pills and tinctures successfully passed the re-certification by the State Food and Drug Administration.

In January 2008, Qinghai Pharmaceutical Co., Ltd. won the title of "Top Ten Private Enterprises in Qinghai Province in 2007".

In May 2008, the company donated medical equipment and medicines worth RMB 503,800 to the earthquake-stricken areas in Sichuan, and donated RMB 120,000.

In May 2008, Qinghai Pharmaceutical Co., Ltd. won the honorary title of "National Outstanding Price Monitoring Designated Unit".

In September 2008, the company established the "Sanpu Pharmaceutical Youth United Association".

In October 2008, the company’s 12th meeting of the fifth session of the Board of Directors reviewed and approved the plan for issuing shares to purchase assets and major asset reorganization (related transactions).

In January 2009, the company won the honorary title of "Top Ten Customer Satisfaction Brands in the Country (Industry)".

In March 2009, the company’s Xinnaoxin capsules were selected into the Shandong Province New Rural Cooperative Medical Care Essential Drugs Catalog.

In May 2009, the company passed the health food Good Manufacturing Practice (GMP) re-certification.

In September 2009, Qinghai Pharmaceutical Co., Ltd. was selected as the drug distribution unit for the Li Ka Shing Foundation Hospice Home.

In October 2009, the company's products Lifei Tablets and Xinnaoxin Capsules entered the military's rational medical drug catalog.

In November 2009, the company successfully passed the re-certification of pills (water pills, water honey pills, concentrated pills, honey pills), oral liquids and decoctions.

In November 2009, the company successfully registered the Chinese domain names "Sanpu Pharmaceutical.China", "Sanpu Pharmaceutical Company", etc.

In December 2009, 24 varieties of the 5 major dosage forms produced by the company were included in the "National Essential Drugs List (Equipment and Use Part of Primary Medical and Health Institutions) (2009 Edition)" (Ministry of Health Order No. 69) , including Jiuwei Qianghuo Granules, Isatis Granules, Compound Danshen Tablets, Fuzi Lizhong Pills, Huoxiang Zhengqi Water, Shengmai Yin, etc.

In December 2009, the company produced Hepatitis B Jian Tablets, Lifei Tablets, Xinnaoxin Capsules, Jiuwei Qianghuo Granules, Isatis Granules, Compound Danshen Tablets, Fuzi Lizhong Pills, Huoxiang Zhengqi Water, Sheng 61 varieties of 6 major dosage forms including Maiyin are included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2009 Edition)".

On June 19, 2010, the company was rated as the "National Customer Satisfaction Brand" in the second national customer satisfaction evaluation event.

On September 26, 2010, the equity of Far East Cable 100, the equity of New Far East 100 and the equity of Compound Technology 100, the subject assets of the company's non-public issuance of shares, were changed to the name of Sanpu Pharmaceutical, and were registered in the industrial and commercial The registration management authority has completed the industrial and commercial change registration procedures.

On September 30, 2010, the share registration procedures for the company's non-public issuance of 307,432,684 shares were completed at the Shanghai Branch of China Securities Depository and Clearing Co., Ltd., and were approved by China Depository and Clearing Co., Ltd. The Shanghai branch issued a securities change registration certificate

On September 30, 2010, the company's registered capital was changed to RMB 427,432,684, and the paid-in capital (share capital) was RMB 427,432,684. , and complete the industrial and commercial change registration procedures at the industrial and commercial registration authority.

On December 1, 2010, the company's "Qifeng Granules" was listed as a national protected traditional Chinese medicine variety.

On December 29, 2010, the company's board of directors reviewed and approved the plan for a non-public issuance of shares of no more than 72 million shares at a price of no less than 21.69 yuan per share.

On January 13, 2011, Qinghai Pharmaceutical Co., Ltd. won the honorary title of "Integrity Private Enterprise" in Qinghai in 2010.

On January 20, 2011, the company’s first extraordinary shareholders’ meeting in 2011 reviewed and approved the non-public issuance of shares plan.

On April 3, 2011, the company laid the foundation stone for the new factory project in the Xining Economic and Technological Development Zone Biotechnology Industrial Park.

On May 27, 2011, the company's "Sanpu" registered trademark won the title of China's Well-known Trademark.

On July 13, 2011, the company was shortlisted for the 297th place on Fortune's 2011 list of China's top 500 companies.

On July 20, 2011, the company’s application for non-public issuance of shares was reviewed and approved by the China Securities Regulatory Commission.

On August 4, 2011, the company’s application for non-public issuance of shares was approved by the China Securities Regulatory Commission.

On September 5, 2011, the company's wholly-owned subsidiary Far East Maimai Bao Network Technology Co., Ltd. was unveiled and the three major business platforms - Cable Network, Cable Maimai Bao, and China Cable Materials Exchange were grandly opened.

On October 11, 2011, Far East Composite Technology Co., Ltd. participated in the formulation of national standards for composite core rods for overhead conductors.

On November 5, 2011, the company's new cable product series was once again selected into the "Famous New Mechanical and Electrical Products Catalog".

On November 26, 2011, the company’s non-public issuance of shares was successfully completed.

On January 2, 2012, 15 new cable products of the company passed provincial appraisal.

On January 6, 2012, Qinghai Pharmaceutical Co., Ltd. successfully passed the GSP certificate renewal acceptance.

On January 29, 2012, Far East Cable Co., Ltd. successfully developed cold-resistant environmental protection rubber for wind power cables.

On February 22, 2012, Far East Cable Co., Ltd.’s new rubber-sheathed cable technology won the national invention patent.

On March 20, 2012, Far East Cable Co., Ltd.’s overhead wire duralumin conductor won the first prize of Yixing Science and Technology Progress Award.

On April 13, 2012, Sanpu Pharmaceutical was selected into the top 20 most competitive brands in the pharmaceutical industry in China.

On May 19, 2012, the company won the "Excellent Board of Directors Award" at the Golden Roundtable Forum of Chinese Listed Company Boards and the 8th "Golden Roundtable Award".

On July 13, 2012, Sanpu Pharmaceutical was once again selected into the "Top 500 Companies in China".

On July 21, 2012, Sanpu Pharmaceutical won the honorary title of "The Happiest Enterprise in 2011-2012".

On July 25, 2012, Wan Liyang, secretary of the company's board of directors, won the "2011 Top 100 Board Secretaries of China's Main Board Listed Companies" award.

On August 14, 2012, Far East Cable Co., Ltd.’s power and control tray cables and wind turbine tray cables successfully passed the U.S. UL certification.

On December 9, 2012, the company won the runner-up among the top 100 companies in the "Top 100 Growth Enterprises in China (Listed Companies)".

On January 5, 2013, Sanpu Pharmaceutical won the Excellence Award in the First China Listed Company Best Annual Report Award.

On January 8, 2013, Sanpu Pharmaceutical won the "Industrial Investment Contribution Award" from the People's Government of Qinghai Province.

On May 26, 2013, Sanpu Pharmaceutical won the Best Social Responsibility Award for Chinese Listed Companies in the 8th "Public Securities Cup".